Janus kinase (JAK) inhibitors, including baricitinib, block cytokine signaling and are effective disease-modifying treatments for several autoimmune diseases. Whether baricitinib preserves β-cell ...
Therapeutic effects were sustained off treatment, with persistent reduction in HbA1c and improvement in beta-cell function 3 months after last dose, suggesting disease-modifying potential of ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A single 14-day course of the monoclonal ...
REDWOOD CITY, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced the presentation of ...
A new nanoscale scanning technique developed at Imperial College London could lead to better-designed beta-blockers to slow the development of heart failure, researchers believe. A new nanoscale ...
-- Protein expression in muscle was sustained for two years following treatment in the low dose cohort, with mean beta-sarcoglycan expression of 54% at 24 months, compared to 36% at Day 60, as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback